- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
October 8th, 2007
A swaggering Texas investor with a famous name wants Big Pharma to pick up the tab for the International Space Station when NASA eases off.
Thomas Pickens III thinks the pharmaceutical industry and the space station need each other.
Drug discovery is an arduous and extremely expensive project. But in space, molecules do miraculous things. Disease-causing proteins crystallize so well -- growing larger and clearer -- that finding a drug to stop the protein's damaging activities could happen months, if not years, faster.
Scientists have known for decades that some science works better in space -- but it hasn't been easy to get experiments up there. Now, with NASA planning to reduce its $2.6 billion annual investment beginning in 2015, the agency is throwing the space station open for private enterprise. And the Texas financial scion and multimillionaire is ready to transform space science with an injection of capitalism.
|Related News Press|
Study reveals how herpes virus tricks the immune system February 5th, 2016
Hepatitis virus-like particles as potential cancer treatment February 5th, 2016
Lithium battery catalyst found to harm key soil microorganism February 7th, 2016
Discovery of the specific properties of graphite-based carbon materials February 6th, 2016
Scientists build a neural network using plastic memristors: A group of Russian and Italian scientists have created a neural network based on polymeric memristors -- devices that can potentially be used to build fundamentally new computers January 28th, 2016
Deep Space Industries teams with UTIAS Space Flight Laboratory to demonstrate autonomous spacecraft maneuvering: SFL and DSI demonstrate enabling technology for low-cost asteroid missions and constellations January 25th, 2016